Back to PRIMECAP MANAGEMENT CO/CA/ PRIMECAP MANAGEMENT CO/CA/

BMRNBMRN
Showing 8 of 31 quarters

Position history for PRIMECAP MANAGEMENT CO/CA/PRIMECAP MANAGEMENT CO/CA/'s holdings in BIOMARIN PHARMACEUTICAL INC

PRIMECAP MANAGEMENT CO/CA/ holds 14.2M shares of BMRN (BIOMARIN PHARMACEUTICAL INC), worth $812M as of 2026-Q2. The position was decreased (-0.0% shares). BMRN represents 0.5% of PRIMECAP MANAGEMENT CO/CA/'s portfolio.

Current Value

$812M

Current Shares

14.2M

Total Value Change

-$514.2M

Total Shares Change

-4.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
14.2M
-0.0%
$812M0.5%$57.22
0
2026-Q1
Decreased
14.2M
-2.4%
$801.8M0.6%$56.49
0
2025-Q4
Decreased
14.5M
-4.5%
$864.7M0.7%$59.43
0
2025-Q3
Decreased
15.2M
-3.4%
$824.8M0.6%$54.16
0
2025-Q2
Decreased
15.8M
-11.3%
$867M0.7%$54.97
0
2025-Q1
Decreased
17.8M
-2.3%
$1.3B1.0%$70.69
0
2024-Q4
Decreased
18.2M
-3.6%
$1.2B0.9%$65.73
0
2024-Q3
Increased
18.9M
+0.4%
$1.3B1.0%$70.29
45

Other major holders of BMRN: BNP PARIBAS FINANCIAL MARKETS, Capital Research Global Investors, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used